172 related articles for article (PubMed ID: 29600428)
21. In vitro and in vivo effects of JAK2 inhibition in chronic myelomonocytic leukemia.
Geissler K; Jäger E; Barna A; Sliwa T; Knöbl P; Schwarzinger I; Gisslinger H; Valent P
Eur J Haematol; 2016 Dec; 97(6):562-567. PubMed ID: 27157043
[TBL] [Abstract][Full Text] [Related]
22. Age-related mutations and chronic myelomonocytic leukemia.
Mason CC; Khorashad JS; Tantravahi SK; Kelley TW; Zabriskie MS; Yan D; Pomicter AD; Reynolds KR; Eiring AM; Kronenberg Z; Sherman RL; Tyner JW; Dalley BK; Dao KH; Yandell M; Druker BJ; Gotlib J; O'Hare T; Deininger MW
Leukemia; 2016 Apr; 30(4):906-13. PubMed ID: 26648538
[TBL] [Abstract][Full Text] [Related]
23. Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients.
Geissler K; Jäger E; Barna A; Gurbisz M; Graf T; Graf E; Nösslinger T; Pfeilstöcker M; Tüchler H; Sliwa T; Keil F; Geissler C; Heibl S; Thaler J; Machherndl-Spandl S; Zach O; Weltermann A; Bettelheim P; Stauder R; Zebisch A; Sill H; Schwarzinger I; Schneeweiss B; Öhler L; Ulsperger E; Kusec R; Germing U; Sperr WR; Knöbl P; Jäger U; Hörmann G; Valent P
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344757
[TBL] [Abstract][Full Text] [Related]
24. IL-4 stimulates the growth of chronic myelomonocytic leukemia cells (CMMoL) once leukemic transformation has occurred.
Yanagisawa K; Hatta N; Watanabe I; Horiuchi T; Hasegawa H; Fujita S
Leukemia; 1995 Jun; 9(6):1056-9. PubMed ID: 7596169
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML.
Niyongere S; Lucas N; Zhou JM; Sansil S; Pomicter AD; Balasis ME; Robinson J; Kroeger J; Zhang Q; Zhao YL; Ball M; Komrokji R; List A; Deininger MW; Fridley BL; Santini V; Solary E; Padron E
Leukemia; 2019 Jan; 33(1):205-216. PubMed ID: 30026572
[TBL] [Abstract][Full Text] [Related]
26. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.
Loghavi S; Curry JL; Garcia-Manero G; Patel KP; Xu J; Khoury JD; Torres-Cabala CA; Nagarajan P; Aung PP; Gibson BR; Goodwin BP; Kelly BC; Korivi BR; Medeiros LJ; Prieto VG; Kantarjian HM; Bueso-Ramos CE; Tetzlaff MT
J Cutan Pathol; 2017 Dec; 44(12):1075-1079. PubMed ID: 28885734
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia.
Bacher U; Haferlach T; Schnittger S; Kreipe H; Kröger N
Br J Haematol; 2011 Apr; 153(2):149-67. PubMed ID: 21401573
[TBL] [Abstract][Full Text] [Related]
28. The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations.
Franzini A; Pomicter AD; Yan D; Khorashad JS; Tantravahi SK; Than H; Ahmann JM; O'Hare T; Deininger MW
Blood Adv; 2019 Oct; 3(20):2949-2961. PubMed ID: 31648319
[TBL] [Abstract][Full Text] [Related]
29. Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia.
Kloos A; Mintzas K; Winckler L; Gabdoulline R; Alwie Y; Jyotsana N; Kattre N; Schottmann R; Scherr M; Gupta C; Adams FF; Schwarzer A; Heckl D; Schambach A; Imren S; Humphries RK; Ganser A; Thol F; Heuser M
Leukemia; 2020 Nov; 34(11):2951-2963. PubMed ID: 32576961
[TBL] [Abstract][Full Text] [Related]
30. Chronic myelomonocytic leukemia as a cause of fatal uncontrolled inflammation in familial Mediterranean fever.
Awad F; Georgin-Lavialle S; Brignier A; Derrieux C; Aouba A; Stankovic-Stojanovic K; Grateau G; Amselem S; Hermine O; Karabina SA
Orphanet J Rare Dis; 2015 Jun; 10():76. PubMed ID: 26076658
[TBL] [Abstract][Full Text] [Related]
31. Aberrant GM-CSF signal transduction pathway in juvenile myelomonocytic leukemia assayed by flow cytometric intracellular STAT5 phosphorylation measurement.
Gaipa G; Bugarin C; Longoni D; Cesana S; Molteni C; Faini A; Timeus F; Zecca M; Biondi A
Leukemia; 2009 Apr; 23(4):791-3. PubMed ID: 18830265
[No Abstract] [Full Text] [Related]
32. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
Ouyang Y; Qiao C; Chen Y; Zhang SJ
Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919
[TBL] [Abstract][Full Text] [Related]
33. How I treat chronic myelomonocytic leukemia.
Solary E; Itzykson R
Blood; 2017 Jul; 130(2):126-136. PubMed ID: 28572287
[TBL] [Abstract][Full Text] [Related]
34. Granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced STAT5 activation and target-gene expression during human monocyte/macrophage differentiation.
Lehtonen A; Matikainen S; Miettinen M; Julkunen I
J Leukoc Biol; 2002 Mar; 71(3):511-9. PubMed ID: 11867689
[TBL] [Abstract][Full Text] [Related]
35. Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells.
Hanazono Y; Odai H; Sasaki K; Iwamatsu A; Yazaki Y; Hirai H
Acta Haematol; 1996; 95(3-4):236-42. PubMed ID: 8677749
[TBL] [Abstract][Full Text] [Related]
36. Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate.
Taoka K; Arai S; Kataoka K; Hosoi M; Miyauchi M; Yamazaki S; Honda A; Aixinjueluo W; Kobayashi T; Kumano K; Yoshimi A; Otsu M; Niwa A; Nakahata T; Nakauchi H; Kurokawa M
Sci Rep; 2018 Oct; 8(1):15855. PubMed ID: 30367142
[TBL] [Abstract][Full Text] [Related]
37. Aberrant phosphorylation of STAT5 by granulocyte-macrophage colony-stimulating factor in infant cytomegalovirus infection mimicking juvenile myelomonocytic leukemia.
Nishio N; Takahashi Y; Tanaka M; Xu Y; Yoshida N; Sakaguchi H; Doisaki S; Hama A; Muramatsu H; Shimada A; Kojima S
Leuk Res; 2011 Sep; 35(9):1261-4. PubMed ID: 21571368
[TBL] [Abstract][Full Text] [Related]
38. Bryostatin 1: a potential anti-leukemic agent for chronic myelomonocytic leukemia.
Lilly M; Brown C; Pettit G; Kraft A
Leukemia; 1991 Apr; 5(4):283-7. PubMed ID: 2027297
[TBL] [Abstract][Full Text] [Related]
39. Deoxyribonucleic acid triplex formation inhibits granulocyte macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cells.
Kochetkova M; Iversen PO; Lopez AF; Shannon MF
J Clin Invest; 1997 Jun; 99(12):3000-8. PubMed ID: 9185524
[TBL] [Abstract][Full Text] [Related]
40. Chronic myelomonocytic leukemia: myeloproliferative variant.
Onida F; Beran M
Curr Hematol Rep; 2004 May; 3(3):218-26. PubMed ID: 15087071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
